- DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells
-
Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X
- KMID: 2155436
- Exp Mol Med.
- 2015 Sep;47(9):e182.
- doi: 10.1038/emm.2015.57
Although methyltransferase has been recognized as a major element that governs the epigenetic regulation of the genome during temozolomide (TMZ) chemotherapy in glioblastoma multiforme (GBM) patients, its regulatory effect on... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
-
Xie D, Shi J, Zhou J, Fan J, Gao Q
- KMID: 2541400
- Clin Mol Hepatol.
- 2023 Apr;29(2):206-216.
- doi: 10.3350/cmh.2022.0402
Liver cancer is the fourth most prevalent and the second most lethal cancer in China. Hepatitis B virus (HBV) infection represents a major risk factor for hepatocellular carcinoma (HCC). Liver... -
- CITED
-
- Close
- SHARE
-
- Close
- The Core Knowledge and Skills of Nursing Competency Regarding Mealtime Assistance for Hemiplegic Patients in China
-
Chen H, Nakatani H, Liu T, Zhao H, Xie D
- KMID: 2502399
- Asian Nurs Res.
- 2020 May;14(2):129-135.
- doi: 10.1016/j.anr.2020.04.005
Purpose: Hemiplegic patients often experience malnutrition and feeding risks due to disabilities and inadequate nursing support; nursing roles regarding mealtime assistance remain unclear in China. Therefore, this study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Intervention to Rescue Hirschsprung Disease in a Rat Model
-
Stamp LA, Obermayr F, Pontell L, Young HM, Xie D, Croaker DH, Song ZM, Furness JB
- KMID: 2381304
- J Neurogastroenterol Motil.
- 2015 Oct;21(4):552-559.
- doi: 10.5056/jnm15079
BACKGROUND/AIMS: Rats with a spontaneous null mutation in endothelin receptor type B or Ednrb (sl/sl; spotting lethal) lack enteric neurons in the distal bowel and usually die within the first... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
-
Wang L, Wu Z, Xie D, Zeng R, Cheng W, Hu J, Huang S, Zhou S, Zhong R, Su Y
- KMID: 2464414
- Cancer Res Treat.
- 2019 Apr;51(2):685-695.
- doi: 10.4143/crt.2018.250
PURPOSE: This study aims to investigate the feasibility of contouring target volume according to residual tumor and decreasing the dose to the tumor regression field after induction chemotherapy (IC) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
-
Li X, Huang H, Xu B, Guo H, Lin Y, Ye S, Yi J, Li W, Wu X, Wang W, Zhan H, Xie D, Peng J, Cao Y, Pu X, Guo C, Hong H, Wang Z, Fang X, Zhou Y, Lin S, Liu Q, Lin T
- KMID: 2454284
- Cancer Res Treat.
- 2019 Jul;51(3):919-932.
- doi: 10.4143/crt.2018.230
PURPOSE: Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone administered every 3 weeks (R-CHOP-21) is the standard care for diffuse large B-cell lymphoma (DLBCL). It is unknown whether the dose-dense R-CHOP... -
- CITED
-
- Close
- SHARE
-
- Close
